Are you Dr. Bierman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 60 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
988102 Nebraska Medical Ctr
Omaha, NE 68198Phone+1 402-559-9800Fax+1 402-559-4835
Summary
- Dr. Philip Bierman, MD is an oncologist in Omaha, Nebraska. He is currently licensed to practice medicine in Nebraska, California, and Iowa. He is affiliated with Nebraska Medicine - Nebraska Medical Center and Nebraska Medicine - Bellevue.
Education & Training
City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1986
University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 1983 - 1985- University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1979 - 1983
University of Missouri Kansas City School of MedicineClass of 1979
Certifications & Licensure
CA State Medical License 1985 - Present
NE State Medical License 1981 - 2024
IA State Medical License 1982 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
Clinical Trials
- Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy Start of enrollment: 2008 Jun 01
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15
- Leukine (Sargramostim) for Parkinson's Disease Start of enrollment: 2013 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 126 citationsPrognostic value of cellular proliferation and histologic grade in follicular lymphoma.Anita R. Martin, Dennis D. Weisenburger, Wing C. Chan, Elizabeth I. Ruby, James R. Anderson
Blood. 1995-06-15 - 152 citationsAutotransplants for Hodgkin's disease in patients never achieving remission: A report from the autologous blood and marrow transplant registryHillard M. Lazarus, Philip A. Rowlings, Mei-Jie Zhang, Julie M. Vose, James O. Armitage
Journal of Clinical Oncology. 1999-02-01 - 64 citationsThe International Prognostic Factors Project score for advanced Hodgkin’s disease is useful for predicting outcome of autologous hematopoietic stem cell transplantationP. J. Bierman, James C. Lynch, Robert G. Bociek, V. L. Whalen, Anne Kessinger
Annals of Oncology. 2002-09-01
Professional Memberships
- Member
